Accretion Nutraveda Ltd.

BSE: 544694

Accretion Nutraveda Live Share Price Today, Share Analysis and Chart

Name: Accretion Nutraveda Ltd.: Is Infosys Ltd. worth buying?
Item: Accretion Nutraveda Ltd.
Rating: 1.44808325
Author: Trendlyne DVM scores

aboutAccretion Nutraveda Ltd. (formerly known as Nutraveda Inc. and currently known as Suveda Inc.) is a specialized Ayurvedic wellness company and a 100% subsidiary of Kerala Ayurveda Ltd. (KERALAYUR). The company functions as a key vehicle for t... Read More

0.00(0.00%)

1,000

BSE Volume

BSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

37.6 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

6Positive9Negative

40.0%Pass in checklist

045

100

Check P/E Buy Sell Zone

Strong Sell Zone

90.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Accretion Nutraveda Stock Price Analysis

Week Price Range 6.1% 1 Week return	290 (LTP) 271.8290 LowHigh
Month Price Range -4.9% 1 Month return	290 (LTP) 271.8305 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Accretion Nutraveda annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Accretion Nutraveda Mar-2026 Annual Revenue is Rs 34 Cr which is growth of 110.0% YoY.
POSITIVE
Annual Net Profit Accretion Nutraveda Mar-2026 Annual Net Profit is Rs 5 Cr which is growth of 94.0% YoY.

Accretion Nutraveda Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
SR_A Total Rev. Ann. ⌄	121.5%	33.7	16.1	5.2	3.1	0.6
TotalOperatingRevenues_A Operating Rev. Ann.	126.3%	33.6	16	5	2.9	0.6
OI_A Other Income Ann.	-20.6%	0.1	0.1	0.2	0.2
OEXPNS_A Operating Exp. Ann.	126.4%	26.7	12.3	3.8	2.3	0.6
OEXPNS_A Operating Exp. Ann.	126.4%	26.7	12.3	3.8	2.3	0.6
OP_A Operating Profit Ann.	125.7%	6.9	3.7	1.2	0.6	-0
OPMPCT_A OPM Ann. %	0.3%	20.45%	23.19%	23.55%	20.24%	-3.48%
TotalExpenses_A Total Exp. Ann. ⌄	114.2%	27.5	12.9	4.3	2.8	1
OtherExpenses_A Other Exp. Ann.	44.2%	1.5	1.3	0.7	0.5	0.3
EmployeeBenefitExpenses_A Employee Exp. Ann.	122.4%	1.1	0.5	0.3	0.1	0
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	106.1%	7	3.8	1.4	0.8	-0
EBIDTPCT_A EBITDA Ann. margin %	-6.9%	20.78%	23.52%	27.24%	25.71%	-2.87%
INT_A Interest Ann.	35.7%	0.5	0.4	0.2	0.2	0.2
DEP_A Depr.	0%	0.3	0.2	0.3	0.3	0.2
PBT_A PBT Ann.	174.4%	6.2	3.2	0.9	0.3	-0.4
TAX_A Tax Ann.	-	1.1	0.6	0.1	0	0
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	157.1%	5.1	2.6	0.8	0.3	-0.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-
NP_A Net Profit Ann.	157.1%	5.1	2.6	0.8	0.3	-0.4
NETPCT_A NPM Ann. %	16%	15.08%	16.32%	16.42%	9.66%	-65.64%
EPS_adj_A EPS Adj. latest Ann.	159.6%	7	3.6	1.1	0.4	-0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

109.3%

2Y CAGR

154.6%

3Y CAGR

121.5%

Net Profit Ann.

1Y CHG

96.2%

2Y CAGR

152.5%

3Y CAGR

157.1%

Operating Exp. Ann.

1Y CHG

117.1%

2Y CAGR

165.1%

3Y CAGR

126.4%

Accretion Nutraveda Technical Analysis

Accretion Nutraveda EMA & SMA

Bullish+7

7 bullish, 0 bearish

Bullish7

Bearish0

5 Day	286.6
10 Day	287.1
12 Day	287.0
20 Day	286.2

26 Day	285.4
50 Day	279.9
100 Day	259.2

Accretion Nutraveda Delivery And Volume

Daily Avg. Delivery Volume %

30 Oct, 2026100.0%

Week93.8%

Month-

Accretion Nutraveda Active Candlesticks

Gap Side By Side White Uptrend Short Line Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Accretion Nutraveda Resistance and Support

290.00

Pivot

First Resistance	290
Second Resistance	290
Third Resistance	290

First Support	290
Second Support	290
Third Support	290

Day RSI	52.2
Day MACD	1.6
Day MFI	90.3
Day MACD Signal Line	2.2

Accretion Nutraveda Beta

1 Month	1.1
1 Year	-

3 Month	0.8
3 Year	-

Accretion Nutraveda Price Change Analysis

↓-4.9%

Over 1 Month

LowHigh

271.8305.0

↑2.1%

Over 3 Months

LowHigh

265.5313

↑8.4%

Over 6 Months

LowHigh

242.1313

Over 1 Year

LowHigh

150.1313

Accretion Nutraveda Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Ankurkumar Shantilal Patel	Promoter	1,064,000	14.7 %
Radiant Global Fund-Class B Participating Shares	Fii	78,000	1.1 %
Huf	Public	109,000	1.5 %
Unicorn Fund	Dii	364,000	5.0 %

HISTORICAL PROMOTER HOLDING

Promoters holding remains unchanged at 73.48% in Sep 2026 qtr

HISTORICAL FII HOLDING

FII/FPI holding remains unchanged at 1.08% in Sep 2026 qtr

HISTORICAL MF HOLDING

All Shareholding details

Accretion Nutraveda Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
PRIYANKABEN JAYKUMAR VORA	Bulk	Sell	30 Sep 2026	299.14	58,000	BSE
SERA INVESTMENTS & FINANCE INDIA LIMITED	Bulk	Purchase	30 Sep 2026	299.45	107,000	BSE
LAKSHMISHREE INVESTMENT & SECURITIES PRIVATE LIMITED	Bulk	Sell	17 Sep 2026	296	62,000	BSE
NAMAMIKASHI HOTEL PRIVATE LIMITED	Bulk	Purchase	17 Sep 2026	296	62,000	BSE
TRADE PULSE BROKING PRIVATE LIMITED	Bulk	Purchase	29 Jul 2026	284.28	88,000	BSE
RADIANT GLOBAL FUND-CLASS B PARTICIPATING SHARES	Bulk	Sell	17 Feb 2026	168.52	359,000	BSE
SUNFLOWER BROKING PRIVATE LIMITED	Bulk	Purchase	05 Feb 2026	185.30	1,000	BSE
SUNFLOWER BROKING PRIVATE LIMITED	Bulk	Sell	05 Feb 2026	181.73	77,000	BSE
DHIRAJBHAI VAGHJIBHAI KORADIYA	Bulk	Purchase	04 Feb 2026	191	94,000	BSE

All deals

All insider trades

Accretion Nutraveda Corporate Actions

Accretion Nutraveda Board Meetings

Accretion Nutraveda past and upcoming board meetings.

#Ex-Date	Purpose	Notes
131 Oct 2026	Half Yearly Results	-
208 May 2026	Audited Results	-

All Corporate Actions

Accretion Nutraveda Corporate Filings

Accretion Nutraveda BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Date	Announcement Title	Details	Links
31 Oct 2026	Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Press Release / Media Release	Accretion Nutraveda Limited inform the stock exchange regarding press release dated 31st October, 2026	PDF
31 Oct 2026	Accretion Nutraveda Ltd - 544694 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 31St October, 2026	Please find enclosed herewith Outcome of the Board Meeting dated 31st October, 2026	PDF
24 Oct 2026	Accretion Nutraveda Ltd - 544694 - Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Unaudited Financial Results For The Half Year Ended On 30Th September, 2026	Accretion Nutraveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Please find enclosed herewith intimation wrt Board Meeting of the company schedule held on 31.10.2026 for consider and approve unaudited financial result for half year ended on 30th September, 2026	PDF
10 Oct 2026	Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association	Please find enclosed herewith intimation w.r.t Amendments to Memorandum of Association	PDF
10 Oct 2026	Accretion Nutraveda Ltd - 544694 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot	Please find enclosed herewith outcome of Postal Ballot	PDF

VIEW ALL

Accretion Nutraveda - Company Profile

Accretion Nutraveda Management Structure

Accretion Nutraveda management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Paraskumar Vinubhai Parmar	Executive Director,Chief Financial Officer	13.11	Mar 26
Payal Hareshbhai Kotadiya	Company Secretary,Compliance Officer	-	Mar 26

Accretion Nutraveda Board of Directors

Accretion Nutraveda Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Ankurkumar Shantilal Patel	WTD & Executive Director	7.8	Mar 25
Mayur Popatlal Sojitra	ED / MD / Promoter	5.25	Mar 25
Hardik Mukundbhai Prajapati	Non Executive Director	4.65	Mar 25
Paraskumar Vinubhai Parmar	Executive Director & CFO	2.8	Mar 25
Harshad Nanubhai Rathod	Non Executive Director	0.9	Mar 25
Vivek Ashok Kumar Patel	Non Executive Director	0.9	Mar 25
Shruti Gupta	Independent Non Exe. Director	-	Mar 25
Payal Hareshbhai Kotadiya	Company Sec. & Compli. Officer	-	Mar 25
Chand Rameshbhai Kanabar	Additional Director	-	Mar 25
Grishma A Shewale	Additional Director	-	Mar 25

About

Website: www.accretionnutraveda.com

About the company - Business Profile

Accretion Nutraveda Ltd. (formerly known as Nutraveda Inc. and currently known as Suveda Inc.) is a specialized Ayurvedic wellness company and a 100% subsidiary of Kerala Ayurveda Ltd. (KERALAYUR). The company functions as a key vehicle for the parent group’s international expansion, particularly in the United States, providing traditional Ayurvedic healing services and herbal products.

Key Points

Key Facts:
- Founded: Originally incorporated on December 19, 1997.
- Headquarters: USA (operating as Suveda Inc.).
- Parent Company: Kerala Ayurveda Ltd. (owns 100% stake).
- Listing: The parent company, Kerala Ayurveda Ltd., is listed on the BSE (Stock Code: 507794).
Operations and Resources:
- The company operates primarily in the US market, focusing on Ayurvedic consultations, therapies, and the distribution of Ayurvedic medicines.
- It works in conjunction with other group entities like the Ayurvedic Academy Inc. (USA) to provide holistic health solutions.
Market and Significance:
- Serves the growing global demand for natural and alternative medicine.
- Acts as a strategic bridge for the parent company to access the North American wellness market.
Business Model and Expertise:
- The company follows a service-led product model where clinical consultations drive the sale of proprietary Ayurvedic formulations.
- It excels in integrating ancient Ayurvedic practices with modern wellness standards suitable for international regulatory environments.
Revenue and Financials (FY 2024-25):
- Consolidated Context: For FY 2024-25, the parent company (Kerala Ayurveda Ltd.) reported a consolidated net revenue of ₹12,033.15 Lakhs, up from ₹10,315.11 Lakhs in the previous year.
- Specific Entity Performance: For the financial year ended March 31, 2025, Suveda Inc. (formerly Nutraveda) reported a turnover of ₹686.85 Lakhs.
- Profitability: The entity reported a loss after taxation of ₹361.09 Lakhs for the same period (FY 2025).
Strategic Initiatives and Future Outlook:
- Brand Consolidation: The renaming from Nutraveda Inc. to Suveda Inc. was part of a broader strategy to streamline international brand identity.
- Synergy: Continued focus on leveraging the parent's R&D and manufacturing base in India (Kerala) to supply high-quality, standardized products to the US clinic network.
- Digital Expansion: Plans include enhancing digital outreach for consultations and e-commerce sales of herbal supplements.

References

Accretion Nutraveda FAQ

Accretion Nutraveda today is trading in the green, up by 0% at ₹290.

Accretion Nutraveda is currently trading up 0% on an intraday basis. In the past week the stock rose 6.13%. Stock has been up 2.13% in the past quarter You can view this in the share price history/seasonality section.

Accretion Nutraveda is listed on BSE with ticker 544694. It's currently trading on BSE at a share price of ₹290.

The market cap of Accretion Nutraveda is ₹209.96 Cr. as of Oct 30, 2026.

Accretion Nutraveda has never announced any dividend since the time of its listing on the BSE exchange.

Accretion Nutraveda has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

Accretion Nutraveda reported ₹33.72 Cr. in revenue, ₹5.07 Cr. in net profit, and ₹7.01 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Accretion Nutraveda.

The PE ratio of Accretion Nutraveda is 41.43 as of Oct 30, 2026.

The PB ratio of Accretion Nutraveda is 5.92 as of Oct 30, 2026.

There are no analyst reports for Accretion Nutraveda.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Accretion Nutraveda Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Accretion Nutraveda Stock Price Analysis

Week Price Range

Month Price Range

Accretion Nutraveda - Annual

Accretion Nutraveda annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Accretion Nutraveda Mar-2026 Annual Revenue is Rs 34 Cr which is growth of 110.0% YoY.

Annual Net Profit Accretion Nutraveda Mar-2026 Annual Net Profit is Rs 5 Cr which is growth of 94.0% YoY.

Accretion Nutraveda Technical Analysis

Accretion Nutraveda EMA & SMA

Accretion Nutraveda Delivery And Volume

Accretion Nutraveda Active Candlesticks

Accretion Nutraveda Resistance and Support

Accretion Nutraveda Beta

Accretion Nutraveda Price Change Analysis

Accretion Nutraveda Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Accretion Nutraveda Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Accretion Nutraveda Corporate Actions

Accretion Nutraveda Board Meetings

Accretion Nutraveda past and upcoming board meetings.

Accretion Nutraveda Corporate Filings

Accretion Nutraveda BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Accretion Nutraveda - Company Profile

Accretion Nutraveda Management Structure

Accretion Nutraveda management structure with salaries, total experience, and qualifications.

Accretion Nutraveda Board of Directors

Accretion Nutraveda Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

Accretion Nutraveda FAQ

How is Accretion Nutraveda today?

Accretion Nutraveda today is trading in the green, up by 0% at ₹290.

How has Accretion Nutraveda performed historically?

Accretion Nutraveda is currently trading up 0% on an intraday basis. In the past week the stock rose 6.13%. Stock has been up 2.13% in the past quarter You can view this in the share price history/seasonality section.

What is the current share price of Accretion Nutraveda on NSE and BSE exchanges?

Accretion Nutraveda is listed on BSE with ticker 544694. It's currently trading on BSE at a share price of ₹290.

What is the market cap of Accretion Nutraveda?

The market cap of Accretion Nutraveda is ₹209.96 Cr. as of Oct 30, 2026.

When did Accretion Nutraveda last pay a dividend, and what has its dividend history been?

Accretion Nutraveda has never announced any dividend since the time of its listing on the BSE exchange.

Has Accretion Nutraveda issued any bonus shares or share splits recently?

Accretion Nutraveda has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

What do the financial statements and annual reports of Accretion Nutraveda Indicate?

Accretion Nutraveda reported ₹33.72 Cr. in revenue, ₹5.07 Cr. in net profit, and ₹7.01 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Accretion Nutraveda according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Accretion Nutraveda.

What is the PE Ratio of Accretion Nutraveda?

The PE ratio of Accretion Nutraveda is 41.43 as of Oct 30, 2026.

What is the PB Ratio of Accretion Nutraveda?

The PB ratio of Accretion Nutraveda is 5.92 as of Oct 30, 2026.

Where can I check the latest Research Reports about Accretion Nutraveda?

There are no analyst reports for Accretion Nutraveda.

How can I be notified of real time alerts about Accretion Nutraveda stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.